PROGRAM | Friday, December 10, 2021

program | saturday, December 11, 2021

program download

The certification has been accepted of the Medical Association of Saxony as follows:

Friday, December 10, 2021 | 10 points
Saturday, December 11, 2021 | 4 points

Room 1 – Plenary Session 1

08:30–10:00 am
Organ specific lipid handling
Chairs: J. Thiery | B. Isermann

details

program | saturday, December 11, 2021

program download

The certification has been accepted of the Medical Association of Saxony as follows:

Friday, December 10, 2021 | 10 points
Saturday, December 11, 2021 | 4 points

10:00–10:15 am | Coffee Break

Room 1 – Workshop 1

10:15–11:20 am
Lipids and liver cell biochemistry
Chairs: T. Schöneberg | M. Matz-Soja

details

Room 2 – Workshop 2

10:15–11:20 am
Lipidomics for patient stratefication
Chairs: U. Ceglarek | A. von Eckardstein

details

11:20–11:40 am | Short Break

Room 1 – Workshop 3

11:40–12:45 pm
Lipid metabolism and NASH
Chairs: T. Kaiser | J. Wiegand

details

Room 2 – Workshop 4

11:40–12:45 pm
Diet, lipid metabolism and diseases
Chairs: R. Burkhardt | A. von Eckardstein

details

12:45–01:15 pm | Lunch Break

Room 1 – Satellite Symposia

01:15–02:15 pm
Satellite Symposia supported by Novartis

details

Room 2 – Satellite Symposia

01:15–02:15 pm
Satellite Symposia supported by 10x Genomics

details

02:15–02:30 pm | Lunch Break

Room 1 – Plenary Session 2

02:30–04:00 pm
Lipid metabolism in cardiovascular disease
Chairs: U. Laufs | M. Stumvoll

details

04:00–04:30 pm | Coffee Break

Room 1 – Workshop 5

04:30–05:10 pm
Mechanisms of atherosclerosis
Chairs: S. Herzig | J. N. Boeckel

details

Room 2 – Workshop 6

04:30–05:10 pm
Adipose tissue – more than a sink for lipids
Chairs: M. Blüher | B. Sheikh

details

Room 1 – Poster Session

05:10–06:25 pm
Chairs: P. Büttner | M. Matz-Soja | K. Shahzad | O. Tiebel | J.N. Boeckel

08:30 – 09:00 am	Lipid handling by endothelial cells of thermogenic adipose tissue J. Herren Abstract
09:00 – 09:30 am	Lipoproteins in chronic kidney disease T. Speer Abstract
09:30 – 10:00 am	Metabolic liver disease in diabetes – From mechanisms to clinical trials S. Herzig Abstract

10:15 – 10:20 am	*Remodelling of the proteasome as a key feature of brown adipocyte differentiation and cold adaptation* N. Willemsen
10:20 – 10:40 am	*Monitoring lipid localisation and molecular identity in cellular transport processes* A. Nadler Abstract
10:40 – 11:00 am	Structural insights into EHD-mediated membrane remodelling and its role in regulating cellular fatty acid uptake O. Daumke Abstract
11:00 – 11:20 am	Quality control of the mitochondrial proteome (including regulation of lipid metabolism) T. Becker Abstract

10:15 – 10:20 am	*Microbiome-derived Trimethylamine N-Oxide is not independently associated with Stable Atherosclerotic Cardiovascular Disease but with Diabetes Mellitus* C. Ringel
10:20 – 10:40 am	*Targeted metabolics – assisting decision making in the critically ill* M. Bauer
10:40 – 11:00 am	Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes R. Wagner Abstract
11:00 – 11:20 am	Cardiogenic shock – new objective prognosis estimation by the CLIP-score H. Thiele Abstract

11:40 – 11:45 am	*The impact of cholesterol lowering drugs on metabolism and epigenetics* A. Rose
11:45 – 12:05 pm	*Hepatic lipid droplet homeostasis and fatty liver disease* N. Krahmer Abstract
12:05 – 12:25 pm	Cell-based strategies against fatty liver B. Christ Abstract
12:25 – 12:45 pm	Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism F. Tacke Abstract

11:40- 11:45 am	*Adipocyte-p53 shapes adipose tissue plasticity upon intermittent fasting in obese mice* I. Reinisch
11:45 – 12:05 pm	*Challenges in clinical lipidomics studies* M. Haid Abstract
12:05 – 12:25 pm	Can we treat metabolic diseases with diet? M. Blüher Abstract
12:25 – 12:45 pm	Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain E. Rinott Abstract

01:15 – 01:45 pm	*From oral – towards nucleic acid-based injection – the evolution in lipid therapie* O. Weingärtner, Jena
01:45 – 02:15 pm	siRNA against PCSK9 as novel lipid lowering drug – a new door opens for practice – first experience and perspectives… U. Schatz, Dresden

02:30 – 03:00 pm	Myeloid cells in cardiovascular health M. Nahrendorf Abstract
03:00 – 03:30 pm	Platelet lipidomics, atherosclerosis, coronary artery disease M. Gawaz Abstract
03:30 – 04:00 pm	Inflammation and atherosclerosis – new mechanisms P. Libby Abstract

04:30 -04:50 pm	The role of red cell eNOS signaling in blood / vessel interactions and systemic hemodynamics M. Cortese-Krott Abstract
04:50 – 05:10 pm	Marcophage proliferation during plaque regression in response to cholesterol lowering I. Hilgendorf Abstract

04:30 – 04:50 pm	Lipolysis as a major regulator of transcription in brown adipocytes S. Mandrup Abstract
04:50 – 05:10 pm	Adipose tissue at the cross roads of metabolism and inflammation J. Ferno